CSIR collaborates with Intel India and IIIT-Hyderabad
The ability to test faster and predict patients at riskis crucial to mitigating SARS-CoV-2 transmission. CSIR is working with Intel India and International Institute of Information Technology (IIIT), Hyderabad to help achieve faster and less expensive COVID-19 testing and coronavirus genome sequencing to understand epidemiology and AI-based risk stratification for patients with comorbidities.
As part of the initiative, Intel India is developing an end-to-end system that consists of multiple applications, testing devices, data collection/aggregation gateways, a data exchange SDK and an AI model-hub platform. CSIR constituent labs such as CSIR-IGIB, CSIR-CCMB, CSIR-IMTECH, CSIR-IIP, CSIR-CLRI and others will work with various hospitals and diagnostic chains in carrying out comprehensive diagnostics. IIIT-Hyderabad will develop risk stratification algorithms that can help in drug and vaccine discovery for long term preparedness to combat the epidemic.